Patients

Total

8

Sex, males/females

3/5

Median age in years (range)

57.5 (26 - 77)

M-Classification

M1a

M1b

M1c

2 (25.0%)

1 (12.5%)

5 (62.5%)

Elevated lactate dehydrogenase values

4 (50%)

BRAF V600E mutation

1 (12.5%)

Median number of prior therapies (range)

1 (1 - 2)

Kind of prior therapies

DTIC

Immunotherapy (Allovectin-7)

Paclitaxel

Treosulfan/gemcitabine

7

1

1

1

Median number of applied cycles of bevacizumab/cisplatin/carboplatin (range)

5 (3 - 17)